Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tanomastat

Drug Profile

Tanomastat

Alternative Names: BAY 12 9566

Latest Information Update: 20 Nov 2000

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer
  • Developer Bayer; National Cancer Institute (Canada)
  • Class Antineoplastics; Butyric acids; Small molecules
  • Mechanism of Action Angiogenesis inhibitors; Matrix metalloproteinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Non-small cell lung cancer; Osteoarthritis; Ovarian cancer; Pancreatic cancer; Small cell lung cancer

Most Recent Events

  • 20 Nov 2000 Results of a phase III study in patients with ovarian cancer have been added to the adverse events and Cancer therapeutic trials section
  • 23 May 2000 BAY 129566 is now called tanomastat (INN)
  • 07 Mar 2000 A clinical study has been added to the adverse events, pharmacokinetics and pharmacodynamics sections

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top